Literature DB >> 20161592

Multidisciplinary Evaluation of Patients With Suspected Lung Cancer.

Kristy Bauman1, Douglas Arenberg.   

Abstract

Lung cancer diagnosis and treatment has evolved to require the input and expertise of multiple diverse medical and surgical specialties. The approach to lung cancer patients requires the adherence to a few principles that include thorough use of staging modalities to assure the proper treatment for each patient, and an understanding of the limitations and advantages of each of these modalities. Evidence is continuing to emerge that supports the notion that diagnostic workup and treatment of lung cancer patients is best done within the context of a multidisciplinary team devoted to this purpose.

Entities:  

Year:  2010        PMID: 20161592      PMCID: PMC2808634          DOI: 10.1097/CPM.0b013e3181c849fe

Source DB:  PubMed          Journal:  Clin Pulm Med


  51 in total

1.  Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.

Authors:  M A Farrell; H P McAdams; J E Herndon; E F Patz
Journal:  Radiology       Date:  2000-06       Impact factor: 11.105

2.  Solitary pulmonary nodules: clinical prediction model versus physicians.

Authors:  S J Swensen; M D Silverstein; E S Edell; V F Trastek; G L Aughenbaugh; D M Ilstrup; C D Schleck
Journal:  Mayo Clin Proc       Date:  1999-04       Impact factor: 7.616

3.  The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer.

Authors:  Antonio E Martin-Ucar; David A Waller; Jane L Atkins; Daniel Swinson; Ken J O'Byrne; Mick D Peake
Journal:  Lung Cancer       Date:  2004-11       Impact factor: 5.705

4.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

5.  Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Paul A Kvale; Paul A Selecky; Udaya B S Prakash
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

6.  Predicting postoperative pulmonary function in patients undergoing lung resection.

Authors:  B G Zeiher; T J Gross; J A Kern; L A Lanza; M W Peterson
Journal:  Chest       Date:  1995-07       Impact factor: 9.410

7.  Impact of limited pulmonary function on the management of resectable lung cancer.

Authors:  Piergiorgio Solli; Francesco Leo; Giulia Veronesi; Giuseppe Curigliano; Alessandro Martinoni; Lorenzo Spaggiari; Carlo Cipolla; Ugo Pastorino
Journal:  Lung Cancer       Date:  2003-07       Impact factor: 5.705

Review 8.  Noninvasive staging of non-small cell lung cancer: a review of the current evidence.

Authors:  Eric M Toloza; Linda Harpole; Douglas C McCrory
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

9.  The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway.

Authors:  P V Murray; M E R O'Brien; R Sayer; N Cooke; G Knowles; A C Miller; V Varney; N P Rowell; A R Padhani; D MacVicar; A Norton; S Ashley; I E Smith
Journal:  Lung Cancer       Date:  2003-12       Impact factor: 5.705

10.  Minimally invasive endoscopic staging of suspected lung cancer.

Authors:  Michael B Wallace; Jorge M S Pascual; Massimo Raimondo; Timothy A Woodward; Barbara L McComb; Julia E Crook; Margaret M Johnson; Mohammad A Al-Haddad; Seth A Gross; Surakit Pungpapong; Joy N Hardee; John A Odell
Journal:  JAMA       Date:  2008-02-06       Impact factor: 56.272

View more
  1 in total

Review 1.  Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions.

Authors:  Graham W Warren; Kenneth D Ward
Journal:  Transl Lung Cancer Res       Date:  2015-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.